Don't want ads? Subscribe or login now.

Bayer Must Face FCA Claims Over Off-Label Trasylol Marketing

By Margaret Harding McGill · June 9, 2015, 6:41 PM EDT

A New Jersey federal judge declined Monday to reconsider his order allowing two False Claims Act claims in a whistleblower's long-running suit against Bayer Corp. for allegedly pushing off-label uses of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

SIMPSON v. BAYER PHARMACEUTICAL CORP. et al

Case Number

2:05-cv-03895

Court

New Jersey

Nature of Suit

Other Statutory Actions

Date Filed

August 05, 2005

Recent Articles By Margaret

January 04, 2016
Justices Asked To Mull Preemption Of NC Workers' Comp Law
December 14, 2015
High Court's DirecTV Ruling Shows No Leeway On Arbitration
December 14, 2015
High Court Boosts Federal Arbitration Rule In DirecTV Case
October 06, 2015
High Court Seeks Its Proper Role In DirecTV Arbitration Row
September 01, 2015
Spokeo Will Impact Verizon ERISA Suit, 5th Circ. Told
August 19, 2015
Price Data Crucial In Retrans Deals, Cable Cos. Tell FCC
August 19, 2015
4th Circ. Upholds End Of IRS Agent's Transgender Bias Suit
July 10, 2015
Locking Up AT&T 'Prisoner' Shirts Just Makes Sense: DC Circ.
June 30, 2015
Tech Cos. Agree To Pay $75.5M To Settle FCA Claims
June 02, 2015
Scan Health Plan Whistleblower Cut From $322M FCA Deal